Genomics, Risk, and Health Decision-Making Laboratory
The mission of the Genomics, Risk, and Health Decision-Making Laboratory, launched in 2016 at Memorial Sloan Kettering Cancer Center, is to optimize the translation of novel discoveries regarding cancer risk and genomics into clinical practice. Our research concerns cancer risk perceptions and health decision-making in patients, families, healthcare providers, and members of the general public across diverse populations and settings.
Jennifer L. Hay, PhD
Research FocusOptimizing the public health benefit of novel basic science, genomics, and epidemiological findings in cancer through research concerning cancer risk perceptions and health decision-making, especially in skin cancer prevention.
Jada G. Hamilton, PhD, MPH
Associate Attending Psychologist
Research FocusAddressing the intersection of behavioral science, cancer prevention, and genomics, with the goal of translating advances in genetic and genomic medicine into improved cancer care.
- Hay JL, Meyer White K, Sussman A, Kaphingst K, Guest D, Schofield E, Dailey YT, Robers E, Schwartz MR, Zielaskowski K, Li Y, Buller D, Hunley K, Berwick M. Psychosocial and cultural determinants of interest and uptake of skin cancer genetic testing in diverse primary care. Public Health Genomics. 2019:1-11. Epub 2019/08/23.
- Hamilton JG, Robson ME. Psychosocial effects of multigene panel testing in the context of cancer genomics. Hastings Center Report. 2019 May;49 Suppl 1:S44-S52. doi: 10.1002/hast.1016.